Abstract: Chemicals are ubiquitous in everyday life. Environmental health practitioners rely on a complex web of regulators and policy bodies to ensure the protection of public health, yet few understand the full extent of this web.
There are over 39 000 chemicals on the world market today, 1 with the potential for this number to increase significantly through new manufacturing techniques such as nanotechnologies. These chemicals are widespread, occurring in everything from the food we eat, to the clothes we wear, to the cars we drive. The regulation of an item that permeates through every facet of our lives is by its nature complex. This complexity is difficult to navigate, particularly when public health practitioners are faced with an adverse health effect from a chemical product. 2 Knowledge of the range of chemical regulators and policy bodies allows for proper engagement with the system.
In an attempt to prevent adverse health effects occurring governments produce policies designed to minimise the exposure of the population to chemicals. Environmental health practitioners are often called upon to design or review these policies for the protection of the public's health, but without having a fundamental understanding of the regulators who can enact this protection it is difficult to ensure the policy developed will be effective and functional.
The following describes the complex web of regulators and policy makers in Australia that underpins the development of comprehensive, well-informed chemicals policy and appropriate practitioner response.
Making the chemical policy web
The current fragmented system of chemical regulation in Australia grew out of Australian federalism. In 1901 the Australian Constitution assigned a limited list of powers to the Commonwealth Government. The regulation of chemicals was not among them, leading to each state developing a unique approach to chemical issues and fragmenting chemical issues across different portfolios. 3 The rise of the environmental movement in the 1960s and 1970s saw the establishment of the first state-based environmental protection agencies and national ministerial councils. Strong nationalisation of chemical policy issues in the form of targeted ministerial councils and national regulators only emerged in the 1990s out of the Hawke Government's 'New Federalism' and attempts to develop national regulatory strategies through the Council of Australian Governments (COAG). This period saw the establishment of national regulators in agricultural and veterinary medicines, therapeutic goods, food, industrial chemicals, as well as various other agencies and ministerial councils. However, since much of the legislative power to implement and monitor controls rests with the states and territories, these agencies were limited in their ability to impose national uniformity of policy.
A third wave of reform began in 2005 with the then Prime Minister's direction to reduce unnecessary regulatory burden on business. 4 COAG set about establishing a high-level taskforce to develop an integrated, national chemicals policy. The main aim of these reforms was to develop uniform regulation between states on chemical issues. These reforms are ongoing and while they are designed to develop uniformity within areas of chemical regulation (such as therapeutics), there is limited development of uniformity between areas of chemical regulation.
Current structure of chemicals policy
The current structure of public health chemicals policy in Australia remains highly fragmented with 12 distinct segments ( Figure 1 ). Some correspond to industrial sectors: therapeutic goods, agricultural and veterinary products, food products and a general category of industrial chemicals. Others developed out of responses to distinct regulatory problems: defective products, exposure standards, acute exposure, transportation of chemicals, land use planning, water, importation and public health policy.
Tables 1a and 1b stratify 10 of these areas with their agencies and functions at federal and state level. Table 2 provides a list of acronyms used in this paper.
Chemicals policy in Australia has the Standing Committee on Chemicals (SCOC) at its centre ( Figure 1 ). The SCOC consists of representatives from the various standing councils and federal government agencies. It heads a regulatory hierarchy in each segment led by a standing council of federal and state ministers, which works towards more uniform national policy responses. 5 These standing councils are generally supported by committees of senior state and federal bureaucrats and any federal government See Table 2 for a list of acronyms used in this figure.
agencies with regulatory responsibility for the area of chemicals policy in question.
Segmented areas of chemicals regulation and policy Therapeutic products, emergency management and public health chemical policy: the Standing Council on Health and the Therapeutic Goods Administration The ministerial Standing Council on Health (SCoH) provides overall leadership in the regulation of therapeutic goods and public health issues arising from chemicals ( Figure 2 ), drawing advice from the Australian Health Ministers' Advisory Council (AHMAC). For public health policy the AHMAC take advice from six key subcommittees, of which the Australian Health Protection Principal Committee (AHPPC) is the most important in terms of chemicals policy. The AHPPC includes federal and state Chief Medical/Health Officers, with representatives from other technical agencies, and provides advice and makes recommendations regarding environmental health policy and environmental threats and emergencies. It draws this advice from the Environmental Health Committee (enHealth) and the National Health Emergency Management Subcommittee (NHEMS).
The National Coordinating Committee on Therapeutic Goods (NCCTG), a sub-committee of AHMAC, has overall responsibility for the Scheduling Policy Framework (SPF), a framework that sets out the national system for applying access restrictions on all poisons (including therapeutics) that pose a potential risk to public health and safety. 6 Chemicals are 'scheduled' according to the degree of risk and the level of control required to protect consumers. A chemical may be referred to one of two committees to determine at what level it is to be scheduled -the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS). These committees provide advice to the Commonwealth Parliamentary Secretary for Health and Ageing (PS) (or their delegate), who has the final decision regarding the scheduling of the chemical in question; 7 The SCoPI is supported by the Primary Industries Standing Committee (PISC). Sitting under the PISC is the National Agvet System Policy Taskforce (NASPT) which is tasked with developing a new national framework for the regulation of agricultural and veterinary chemicals.
The APVMA is the regulator responsible for the assessment and registration of agricultural and veterinary chemical products in Australia. Through the National Registration Scheme the APVMA registers and regulates the manufacture and supply of all pesticides and veterinary medicines used in Australia, up to the point of retail sale.
The APVMA also assesses agricultural and veterinary chemicals or products for potential impacts on human health, the environment, trade and efficacy.
The APVMA contracts the Office of Chemical Safety (OCS) in the Department of Health and Ageing to undertake public health assessments. As part of this assessment, the product may also be classified as a poison, at which point the product is referred to either the ACMS or ACCS for scheduling. The APVMA will set Maximum Residual Levels. These are the highest concentrations of agricultural and veterinary chemical residues permitted in food or animal feed and are set ensuring consumption of foods with these residues does not constitute an undue hazard to human health. The APVMA approves the labelling of a product. They also have the power to refuse an application if they are not satisfied that the product will not be harmful to human beings, and may also put conditions on its manufacture and supply. 8 The APVMA also run a Chemical Review Program and an Adverse Experience Reporting Program.
The control of use of pesticides and veterinary medicines beyond the point of retail sale is the responsibility of state and territory governments (Table 1a) . Under the LGFFR is the Food Regulation Standing Committee (FRSC) which is responsible for coordinating policy advice to the LGFFR.
Sitting below the FRSC is the Implementation SubCommittee (ISC) which develops and supervises the implementation and enforcement of food regulations and standards across the jurisdictions.
Food Standards Australia New Zealand (FSANZ) is the national food regulator responsible for developing and maintaining the Food Standards Code and ensuring the protection of public health and safety around food issues. The Food Standards Code regulates the use of ingredients, the composition of some foods, and the presence of contaminants from food contact materials and environmental sources. FSANZ is also responsible for the labelling of both packaged and unpackaged food. It sets maximum levels for chemicals in food, which includes incorporating pesticide Maximum Residual Levels set by APVMA into food law.
In developing or reviewing any food regulatory measures, FSANZ must have regard to any policy guidelines set by the LGFFR. The implementation and enforcement of the Foods Standards Code is the responsibility of the ISC, and state and local governments.
Defective products: Legislative and Governance Forum on Consumer Affairs and the Australian Competition and Consumer Commission Policy direction around consumer protection stems from the Legislative and Governance Forum on Consumer Affairs (CAF), the ministerial council of federal and state ministers for consumer affairs ( Figure 5 ). Under the CAF sits Consumer Affairs Australia New Zealand (CAANZ), consisting of heads of state and federal consumer affairs departments. In turn, the CAANZ receives policy advice from three advisory committees and the Product Safety Consultative Committee (PSCC). The PSCC provides advice and recommendations on product safety specific policy, education and compliance matters. It also provides advice to the Australian Competition and Consumer Commission (ACCC) on proposed product safety regulations, bans, standards and responses to emerging issues.
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The ACCC is the national regulator of consumer products and administers the Commonwealth Competition and Consumer Act 2010. This Act sets out the Australian Consumer Law.
The powers that the ACCC has over product safety are of most relevance here. Under the Act the Assistant Treasurer has powers to recall or ban products that do not meet certain standards, are defective, or create an imminent risk of death, serious illness or serious injury. The ACCC can undertake assessments of the chemical hazards in products, which may be in conjunction with the National Industrial Chemicals Notification and Assessment Scheme (NICNAS).
The Australian Consumer Law is designed to create a consistent approach to the banning or recalling of products in Australia. As such, state and territory governments are limited in their approaches to recall or ban a product, which will occur at the national level. State and territories have the ability to impose interim bans and consult with the national regulator about product safety issues. (Figure 1 ).
Conclusion
This paper describes the system of chemical regulators and government policy bodies responsible for protecting public health in Australia. Understanding this system should be paramount to any policy maker or public health worker in the area of chemical exposure as it is essential for effective environmental health responses and policy development, and will lead to greater efficacy in environmental health outcomes. See Table 2 for a list of acronyms used in this table. Abstract: Aim: In the absence of published statewide notification data, the aim of this study was to analyse trends in notifiable blood lead levels (hereafter referred to as lead poisoning) in NSW from 1998 to 2008, to help inform lead poisoning notification policy. Methods: NSW blood lead poisoning notification data for 1998-2008 were extracted from the Notifiable Diseases Database and analysed by age, gender and Area Health Service of residence. Results: There were 6000 lead poisoning notifications from 1998 to 2008, with an average annual notification rate of 11.8 per 100 000 population for 1998-2003. This rate declined to an average of 4.0 per 100 000 population in the period 2004-2008. Males accounted for 92% of notifications, and males aged 20-59 years had average notification rates between 20 and 27 per 100 000 population. Children aged 0-4 years had notification rates of 9.3 per 100 000 population in girls and 13.6 per 100 000 population in boys. Conclusion: Notification rates have fallen dramatically, however children aged 0-4 years and men are disproportionately represented in lead poisoning notifications.
Lead is a naturally occurring mineral found within the Earth's crust in many parts of the world. 1 Lead poisoning occuring after exposure to lead has been of public health importance worldwide for centuries. 2 In 2009 the Australian National Health and Medical Research Council made a public statement that there is no safe level of lead exposure, and recommended that all Australians have blood lead levels less than 10 mg/dL. 3 The routes of lead exposure include ingestion, inhalation and skin contact. Once lead is absorbed into the bloodstream it spreads throughout the body, where it can affect the nervous, haematopoietic, endocrine, renal, skeletal and reproductive systems. 1, 4 The potential health outcomes from lead poisoning vary between individuals and are due to the route of exposure, the dose absorbed, the duration of exposure and the person's age. 1, 3, 4 Children and pregnant women are considered the most sensitive to lead exposure; children absorb 40-70% of ingested lead compared to 10-20% in adults, 5 while women exposed before or during pregnancy transfer lead to the foetus via the placenta, and after pregnancy to the infant in breastmilk. 3 Acute lead poisoning occurs at blood lead levels of 70 mg/dL or higher, and is considered a clinical emergency. 3 At these levels, signs and symptoms range from stomach pain and vomiting to encephalopathy and death. The long-term consequences of exposures in children include reduction in intellectual development even when blood lead levels are less than 10 mg/dL. 6 Treatment for lead poisoning is limited to the use of chelating agents that bind to lead in the blood and assist excretion in urine. Chelating agents can be used in adults with levels above 50 mg/dL, 7 whereas chelation in children with levels less than 45 mg/dL does not improve long-term behavioural or cognitive outcomes.
8 There is also concern that chelation therapy will redistribute lead to susceptible organs, including the brain, where it may be reabsorbed. 9 Lead mining and smelter activities that cause lead-rich emissions to be blown into residential areas and deposited as dust in and around houses and gardens are the most common sources of contamination of human environments. 1 In the past lead was used in applications including face powders, and for preserving wine, 2 while more recently lead and lead alloys have been used in everyday products such as paint, car batteries and plastic coatings. 3 In Australia, lead was added to petrol to improve engine combustion performance from the 1930s until 2002, despite public health concerns about lead exposure. 10 The use of leaded petrol resulted in widespread contamination of dust and soil in urban and industrial areas, causing increased blood lead levels in people exposed, particularly children.
11 Improved awareness about the effects of lead and the introduction of legislation in Australia has resulted in the reduction and removal of lead from car fuels and paints.
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In New South Wales (NSW) active screening for lead poisoning has been conducted for children and for workers exposed to lead since the early 1990s. In December 2011, the mandatory notification of blood lead concentrations 15 mg/dL or above was changed, under the NSW Public Health Act 1991*, to the lower level of 10 mg/dL or above.
14 The aim of this study was to describe trends in notifications of lead poisoning in NSW from 1998 to 2008 to help inform public health policy.
Methods
In NSW the notification of lead poisoning is mandatory for hospitals, clinicians and laboratories. Notifications are based on the results of a confirmatory venous blood sample to determine the lead concentration, which is measured in micrograms per decilitre (mg/dL). Between 1998 and 2008, a blood lead concentration of 15 mg/dL or more was classified as lead poisoning and was notifiable to the then NSW Department of Health. 15 Notified cases were then investigated by local public health units. 16 The investigating public health unit staff entered demographic information and blood lead levels of the cases into the Notifiable Diseases Database (NDD), which was used for the collection of notifiable disease case information in NSW until the implementation of the Notifiable Conditions Information Management System in 2010. Data from active surveillance programs conducted in occupational settings and child blood lead screening programs were included in routine NDD data. Active surveillance programs included blood lead screening in children in the north Lake Macquarie area from 1993 to 2006, and continuous surveillance in children in Broken Hill since 1991.
All notifications of lead poisoning in NSW for the period 1998-2008 were extracted from the NDD using the Health Outcomes Information Statistical Toolkit (HOIST). The data were analysed using SAS Ò (version 9.1.3, SAS Institute, Cary, NC, USA) and Microsoft Excel. Population estimates were obtained from the Australian Bureau of Statistics. Due to changes in Area Health Service boundaries, area of residence was defined by the NSW Health pre-2005 (former) Area Health Services (n ¼ 17).
As a major source of lead notifications ceased operation in 2003, analysis by time period was divided into time period 1 (1998-2003) and time period 2 (2004-2008) . Data were analysed by gender, age group, (former) Area Health Service, blood lead concentration and occupation. Occupational variables were identified from a predetermined list in the NDD; some of these served as a proxy for sources of lead exposure (e.g. lead smelter worker or miner).
Results
There were 6000 lead poisoning notifications in NSW for the period 1998-2008, with an average annual notification rate of 8.2 per 100 000 population. The highest annual notification rate was in 1998 (23.0 per 100 000 population, n ¼ 1400). Notification rates declined each year, with the exception of 2000 (Figure 1 ).
Gender and age
Males accounted for 92% (n ¼ 5538) of all notifications with a notification rate of 15.2 per 100 000 population for the period 1998-2008. The highest notification rate for males was 43.0 per 100 000 population in 1998; by 2004, annual notification rates in males had decreased to below 10.0 per 100 000 population (Figure 1 ). For females, the notification rate began at below 5.0 per 100 000 population in 1998 and steadily declined to below 1.0 per 100 000 population in 2008 (Figure 1 ).
People notified with lead poisoning between 1998 and 2008 ranged in age from 0 to 87 years. Men aged 25-34 had the highest notification rate of 27.1 per 100 000 population, while the lowest notification rates were in 10-14-year old boys and girls. The gender differences become more noticeable at 15 years of age (Figure 2 ). Seventy-eight percent of notifications (n ¼ 4701) were observed in men aged 20-59 years, who had an annual notification rate of almost 70.0 per 100 000 population in 1998, which declined to 10.0 per 100 000 population in 2004.
The 0-4-year age group accounted for 9.3% of notifications (n ¼ 559), of which 60% were in boys. The notification rate in girls aged 0-4 years was 9.3 per 100 000 population, and for the same age group of boys, 13.6 per 100 000 population (Figure 2 ). The highest annual Trends in notifiable blood lead levels in NSW notification rate for boys aged 0-4 years was 30.0 per 100 000 population in 1999.
Blood lead concentrations
Blood lead concentrations were recorded for 96.6% (n ¼ 5795) of notifications. Forty-three percent (n ¼ 2503) of blood lead concentrations were in the lowest notifiable range (15-19 mg/dL), while 54% (n ¼ 3011) were in the 20-49 mg/dL range, 2% (n ¼ 125) were in the 50-69 mg/dL range, and 1% (n ¼ 56) were 70 mg/dL or above. Figure 3 shows a further breakdown of notification rates by year, stratified by blood lead concentrations, in men aged 20-59 years, and demonstrates the downward trend in notification rates of blood lead concentrations in all years except 2000. (Figure 4 ). Other occupational categories identified with high notification rates included contractors (13%) and factory workers (10%). The interpretation of this study is limited by data quality, with more than half of adult cases missing occupational data. Because the source of lead exposure was not available, occupation was used as a proxy for the source of exposure. In future, a review of case files from lead poisoning investigations and the recent inclusion of a variable for exposure site in the new notification data management system will help describe sources, without the need to use proxies. There is also likely to be a selection bias due to active surveillance programs, and greater awareness of public health practitioners in geographical areas, age groups and occupations at high risk. Screening has been important for understanding the epidemiology of lead exposure, because the acute symptoms of lead poisoning are not present at lower blood lead concentrations. 1, 3 However, the likely selection bias for children and men means that women will tend to be under-represented in notification data. The reporting of more robust 18 There are marked differences in the ages of notified cases in these two locations. In the former Hunter Area Health Service, 90% of cases were in adults aged 20-59 years, whilst in the former Far West Area Health Service, children aged 0-4 years accounted for 52% (n ¼ 385) of notified cases. In comparison, the former Hunter Area Health Service had 4% (n ¼ 78) of notifications in the 0-4-year age group. An explanation for this difference is the location of Broken Hill city, which is in the immediate vicinity of the active mine site with above ground historical waste disposal, and regional soils that have natural lead deposits. These sources produce ongoing exposure from lead-laden dust in and around houses where children play.
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Occupational exposures are also likely to account for the differences in notification rates between men and women which became more evident from the age of 15 years. In the former Hunter Area Health Service, lead poisoning notifications reduced following the closure of the Lake Macquarie smelter in 2003. 20 Increased lead mining activity in the former Macquarie Area Health Service (Cobar) since 2003 21 has resulted in miners being the most frequently notified occupation. Other occupations and hobbies that have been associated with lead exposures include battery making and recycling, soldering, stained glass manufacture and lead-based paint abatement. 3, 22 Since 1991 the blood lead screening of children in Broken Hill has underpinned education and risk reduction interventions provided to individuals and their families.
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These interventions resulted in almost 75% of children aged 1-4 years recording blood lead levels below 10 mg/dL by 2007. 25 In the north Lake Macquarie area, the positive influence of public health action allowed active surveillance to stop after mean blood lead levels in children decreased to less than 5 mg/dL in 2006, 18 3 years after the closure of the smelter.
From December 2011, the notifiable blood lead level in NSW has been reduced to 10 mg/dL in line with the current National Health and Medical Research Council recommendation. 3 A review conducted by the Centers for Disease Control and Prevention in the United States concluded that there is sufficient evidence for adverse health effects in children and adults at blood lead concentrations below 5 mg/dL. Abstract: Lead poses a health risk to young children with detrimental effects on their intellectual development. Attendance rates for Aboriginal children at routine blood lead screening and at follow-up appointments in Broken Hill, NSW, have declined in recent years. This study sought to identify strategies to improve the participation of Aboriginal children aged 1-4 years in blood lead screening services in Broken Hill. Methods: Attendance rates during the period 2000-2010 were determined using the Broken Hill Lead Management database. From June to August 2011, Aboriginal community members, service providers and public health staff were invited to interviews and focus groups to explore barriers, enablers and suggestions for improving participation. Results: In 2009, 27% of Aboriginal children aged 1-4 years attended blood lead screening and 29% of these children with blood lead levels over 15 mg/dL attended follow-up appointments. Barriers to participation in lead screening services included community perceptions, reduced service capacity, socio-economic and interorganisational factors. Enablers included using a culturally acceptable model, linking lead screening with routine health checks and using the finger-prick method of testing.
Conclusions:
The final report for the study included recommendations to improve participation rates of Aboriginal children including using social marketing, formalising collaboration between health services, supporting disadvantaged families and employing an Aboriginal Health Worker.
Exposure to lead poses a health risk particularly to young children with detrimental effects on their intellectual development. 1 The mining town of Broken Hill, New South Wales (NSW), was built around one of the world's largest silver-lead-zinc ore deposits and has been mined continuously since 1884. In 1991 a survey of pre-school aged children in Broken Hill found lead was a significant public health issue; a state government-funded Lead Management Program was established in 1994 to reduce blood lead levels in children aged 1-4 years. 2 The program which included blood lead screening began as an adequately resourced, stand-alone service until 2001, when it was integrated into existing child health services and its dedi- There is no known threshold defining 'safe' levels of exposure to lead, but the National Health and Medical Research Council currently recommends interventions at a community level when appreciable numbers of children have blood lead levels exceeding 10 mg/dL.
1 Forty percent of Aboriginal children aged 1-4 years screened in 2010 were above 10 mg/dL.
3 Blood lead levels 15 mg/dL and above are notifiable to NSW Health. * In 2010, 21% of Aboriginal children screened had blood lead levels requiring notification. 3 Aboriginal people continue to experience socio-economic disadvantage which places them at greater risk of exposure to behavioural and environmental health risk factors, 4 and this should be taken into consideration in the planning and provision of relevant services.
In 2011, we undertook a study to gain a better understanding of the decline in screening rates in Aboriginal children aged 1-4 years and to identify strategies to improve their participation in blood lead screening services in Broken Hill. The study was undertaken on behalf of the Far West Local Health District.
*
In December 2011, the mandatory notification level changed to 10 mg/dL or above.
Methods
The study took place in two phases. The first involved reviewing data from the Broken Hill Lead Management Program, set up as part of the original lead program to record children's test results. The second phase used qualitative methods to explore emerging themes. 5 Semistructured interviews and focus groups with Aboriginal parents and carers of young children, service providers and public health staff were used to gain a better understanding of:
• the perceptions of the health risks of lead for children • the reason for the downward trend in Aboriginal children's attendance at screening programs • how these declining attendance rates might be improved.
Broken Hill Lead Management database
De-identified data from the Broken Hill Lead Management database from 2000 to 2010 were reviewed. Records for Aboriginal children aged 1-4 years of age were extracted. Duplicates and those with missing blood lead values were excluded, leaving a data set of 864. Attendance rates for annual screening were calculated for children recorded as having attended blood lead screening at least once in a calendar year. Australian Bureau of Statistics Census data for 2001 and 2006 were used to calculate screening rates. 6 Attendance rates for follow-up visits by children whose blood lead levels were 15 mg/dL and above from 2004 to 2010 were also calculated.
Lead Health Program Testing Schedule
Attendance at follow-up appointments was measured against the protocol outlined in the Lead Health Program Testing Schedule and Interventions (available on request from Broken Hill Child and Family Health Services). Children were grouped according to whether or not their follow-up visits were in accordance with recommendations in the protocol. Children with a blood lead level between 11 and 20 mg/dL are requested to return at 6-month intervals for follow-up testing. Children with levels between 21 and 39 mg/dL are requested to return at 3-month intervals and those with levels 40-49 mg/dL at 1-month intervals. Case management including education and home assessment to identify the pathway of lead ingestion is offered to all families of children with blood lead levels over 10 mg/dL.
Interviews and focus groups
Participants with a range of relevant experience, skills and knowledge were invited to interviews and focus groups (Table 1) . Aboriginal parents or carers of young children were invited to informal interviews at an Aboriginal preschool and an Aboriginal playgroup. Interviews were conducted while participants were involved in the routine functions of the centre (e.g. playing with children, helping with morning tea). Service managers were invited to individual interviews in order to explore planning and management strategies. Two interviews were conducted at their place of work and one was by telephone. Three focus groups were conducted with health professionals to facilitate discussion and the exchange of ideas and to reflect on blood lead screening services for Aboriginal families. Participants included lead screening staff, a health promotion officer, an early childhood health nurse, a practice nurse, research staff and an epidemiologist.
Interviews with community members lasted approximately 10 minutes while other interviews and focus groups were 40-60 minutes. Informed consent was obtained from all participants. Confidentiality and privacy were ensured as contributions used in the report were de-identified. Interviews were sound recorded (with the exception of interviews with community members where written records were taken), transcribed, and analysed manually to identify barriers, enablers and strategies. The study investigators verified the resultant material. Improving participation by Aboriginal children in blood lead screening services Follow-up rates for Aboriginal children aged 1-4 years whose blood lead levels were 15 mg/dL and above have declined from 2004 when 79% attended follow-up appointments. In 2009, 29% returned for follow-up and in 2010, 33% returned ( Table 3 ).
The findings from the interviews and focus groups were grouped into common themes to identify why Aboriginal children's attendance at screening programs was declining and how attendance might be improved: barriers, enablers and strategies.
Barriers
Community members generally agreed that health risks and the importance of screening were not well promoted. Many participants recalled risks related to learning and intellectual development but had forgotten health messages about ways to reduce the risk of lead ingestion. Many referred to the fact that there was no practical or financial help for affected families to act on recommendations by health staff (e.g. fixing cracks in ceilings, planting grass over dirt yards) and that this lack of support was a significant barrier to attending screening services. Some community members commented that there were other more important priorities for many families.
Service providers described barriers related to service capacity and funding for key positions. Most agreed that community perceptions were a significant factor in preventing uptake of health services for Aboriginal children: There was wide agreement among service providers that socio-economic barriers needed to be acknowledged and were factors contributing to the decline in attendance at screening services. Service providers commented that families felt there was nothing that could be done to help them if their child had elevated blood lead levels: Service providers also discussed gaps in communication between health services, including no formal meetings to share information or discuss issues related to declining attendance rates and strategies. Some service providers and managers were not aware of information available from the Lead Management database. That services did not share case management of Aboriginal children with high lead levels or do joint home visits were raised as issues for Aboriginal families.
Enablers
Many community members recalled the special lead screening days held at Maari Ma and felt that these encouraged families to come for their children's screening. They also felt that using the finger-prick testing method and assisting with transport to the centre encouraged the community to bring their children for screening. There was wide agreement among service providers and public health staff that linking lead screening with other services such as immunisation and child development checks was proving to be successful in increasing attendance.
Suggestions for action
Many community members wanted to see health messages relating to lead promoted in the community. Most spoke fondly of the old lead mascot 'Lead Ted' and would like to see a return of the specific lead screening days held at Maari Ma.
Service providers agreed that more funding, even if not to health directly, would be helpful in re-engaging with the community in a variety of ways including assisting those in financial need. Further expansion of services at Maari Ma was also seen as important, including ongoing or additional training so that staff could provide case management as well as screening services. Some felt that better use of the Lead Management database would help service providers identify and respond to declining attendance rates for screening of lead in Aboriginal children.
Public health staff were in agreement with the other service providers in terms of barriers and enablers to lead screening. They felt it was important to re-engage with the community, perhaps through the Aboriginal Community Working Party in Broken Hill, to increase confidence that help was available for children with high lead levels.
Discussion
This study shows a steady increase in screening rates for Aboriginal children from 2000 to 2004 despite declining investment in lead awareness and the Lead Management
Program's integration into existing health services. The screening rate for Aboriginal children was high in 2004 (80%) after which it declined. Two factors that may explain the high attendance rates at this time were the special days for lead screening that were taking place at Maari Ma and the role of an Aboriginal Health Worker employed by Child and Family Health Services to identify Aboriginal children who were due for a blood lead test and to encourage and assist families to bring those children to the centre. After 2004 dedicated resources ceased and as a consequence both the position of Aboriginal Health Worker and the special lead screening days at Maari Ma ended. Attendance rates began to decline in annual screening and follow-up. The rates of testing and followup were lowest in 2009 when Maari Ma experienced a decline in workforce capacity. The low rates of follow-up are of concern as they indicate that even children with elevated blood lead levels are not engaging with the available services offered through case management, including education, home visiting, soil sampling and further monitoring of blood lead levels. Attendance and follow-up rates for Aboriginal children increased slightly in 2010, since Maari Ma has begun offering finger-prick testing.
Maari Ma, which now screens the majority of Aboriginal children in Broken Hill, identified logistical barriers to the participation by Aboriginal children in lead screening services related to workforce capacity, the physical space currently available and the difficulty of ensuring the correct environment to conduct the test (e.g. room temperature, dust-free). A new facility is being built and Maari Ma has recently supported a cohort of Certificate IV Aboriginal and Torres Strait Islander Primary Health students, which will help to address these barriers. Some Aboriginal families were not comfortable engaging with government services, an important barrier to health screening as it is the government services which currently provide comprehensive case management of children with elevated blood lead levels. Staff at Maari Ma were concerned that some Aboriginal families have felt judged by government health services and feared having their children removed, particularly when a home visit was recommended.
In terms of improving current participation rates, Maari Ma staff described issues related to service capacity such as having the right people in the right positions with the right training, and issues related to their service model such as face-to-face communication, home visiting to follow-up those who did not attend appointments and providing transport to assist families. This approach suggests that using a culturally appropriate model, combined with other strategies aimed at community engagement are likely to be successful in improving blood lead screening rates for Aboriginal children aged 1-4 years.
Community members expressed concern over the difficulty or inconvenience for some people to prove their Aboriginal status to access Maari Ma health services. There was also some concern that as the Aboriginal community in Broken Hill is small some patients may have a personal relationship with service providers, which may discourage them from using the service. While access to an Aboriginal Community Controlled Heath Service (ACCHS) is important and provides a culturally appropriate and safe environment for families, it is also important for people to have a choice of services.
Recommendations were developed from the findings and from discussions with stakeholders involved in lead management services in Broken Hill and are included in a report prepared for the Far West Local Health District. These recommendations focus on re-engaging with the Aboriginal community to develop and implement programs to promote lead screening, formalising relationships between government and ACCHSs at both the local and regional level, seeking funding to assist disadvantaged families, linking lead screening with routine health visits and re-instating the dedicated position of an Aboriginal Health Worker. Figure 1 and Tables 1 and 2 show notifications of communicable diseases with onset in September and October 2012 in New South Wales (NSW).
Conclusion

Enteric infections
Outbreaks of suspected foodborne disease Eight outbreaks of gastrointestinal disease, thought to be due to consumption of contaminated food and which affected at least 80 people, were reported in September and October 2012. These outbreaks were linked to restaurants or cafes (4), food supplied by caterers (2) and private residences (2) . Salmonella Typhimurium (STm) was found to be the cause for three outbreaks; the implicated food vehicles in two of these outbreaks were raw egg mayonnaise and chicken. In one outbreak multiple foods were consumed and the vehicle was unable to be determined. In another outbreak affecting six groups, norovirus was identified as the cause and oysters were identified as the food vehicle. In other outbreaks the causative organism could not be identified due to either lack of sampling of ill people or of suspected food vehicles.
The Salmonella outbreaks were identified by monitoring of clusters of STm through molecular typing (multiplelocus variable tandem repeat analysis -MLVA). A cluster of 45 cases of a STm MLVA subtype was investigated in September and October. Thirty-five cases of STm were interviewed; 88% had consumed pre-cut chicken pieces in the 3 days prior to onset of illness. Cases continue to be notified and the investigation in collaboration with the NSW Food Authority is ongoing.
Viral gastrointestinal disease
There were 180 outbreaks of gastroenteritis in institutions reported in September and October 2012, affecting at least 2944 people. The previous 5-year average for this period was 148 outbreaks. A total of 87 outbreaks occurred in aged-care facilities, 75 in child-care centres, 15 in hospitals and three in other facilities. In the 83 (46%) outbreaks in which a stool specimen was collected, norovirus was confirmed in cases from 29 (16%) outbreaks and rotavirus was confirmed in 20 (11%).
Respiratory infections Influenza
Influenza activity, as measured by the number of people who presented with influenza-like illness to 59 of the state's largest emergency departments, returned to preseasonal levels in September and October after a peak in mid-July. In addition, the number of people who tested positive for influenza A by diagnostic laboratories decreased to pre-seasonal levels throughout September and October, after a peak in late June. The number of people who tested positive for influenza B also decreased over the reporting period. While this number has yet to return to pre-seasonal levels, it is well below the peak reached in June.
In September, there were:
• 196 presentations to emergency departments (rate 1.3 per 1000 presentations) • 774 cases of laboratory-confirmed influenza including: 269 (35%) influenza A 506 (65%) influenza B.
In October, there were:
• 139 presentations to emergency departments (rate 0.7 per 1000 presentations) • 260 cases of laboratory-confirmed influenza including: 42 (16%) influenza A 218 (84%) influenza B.
For a more detailed report on respiratory activity in NSW see: http://www.health.nsw.gov.au/PublicHealth/ Infectious/influenza_reports.asp.
Vaccine-preventable diseases
Meningococcal disease Eleven cases of meningococcal disease were notified in NSW in September and October 2012 (seven in September and four in October), a decrease from 15 notified in the same period in 2011. The age of the cases ranged from 5 months to 87 years and included six cases aged less than 5 years. There were no deaths due to meningococcal disease notified in this period. Seven (64%) cases were due to serogroup B (for which there is no vaccine), three (27%) were due to serogroup W135, and one (9%) was unable to be typed. Of the 15 cases notified during the same period in 2011, nine (60%) were due to serogroup B, one (7%) was due to serogroup Y, one (7%) was due to serogroup C and the remaining four (27%) were of an undetermined serogroup.
It is recommended that a single dose of vaccine against meningococcal C disease be given to all children at the age of 12 months as well as persons at high risk of disease.
1 Measles Seventy-seven cases of measles were notified in NSW in September and October 2012; all were part of an ongoing outbreak that began in April. This was an increase compared to the six cases reported for the same period in 2011. The age groups most affected were children aged 0-4 years (n ¼ 24), of which 13 were aged less than 1 year, and young adults aged 30-34 years (n ¼ 10). The average age of cases was 17.5 years (range: 6 months-61 years), and 49% were female. Six (8%) cases were Aboriginal people.
Most cases were notified in South Western Sydney Local Health District (71%), followed by Western Sydney (Parramatta) (17%), however outbreak-associated cases were also reported in the Illawarra Shoalhaven (n ¼ 4), North Coast (Port Macquarie) (n ¼ 3) and South Eastern Sydney (n ¼ 1) LHDs as well as Justice Health (n ¼ 1). Of the 77 notifications, 64 (83%) were laboratory confirmed.
The majority (81%) of the cases were not vaccinated for measles. Of the 15 cases that were reported to have been vaccinated, five were documented as partially or fully vaccinated for age. Of these, one 10-14-year old had received, according to the Australian Childhood Immunisation Register, two doses; two 10-14-year olds had received one dose; and a 9-month old and a 10-month old who were vaccinated as contacts of confirmed cases had received one dose each.
Pertussis
During September and October, 776 cases of pertussis were notified with onset in the period in NSW, less than one-third of the 2410 cases notified for the same period in 2011. Most cases were in the 5-9-year age group (n ¼ 237), followed by the 0-4-year (n ¼ 140) and the 10-14-year age groups (n ¼ 129).
Direct protection for young infants remains available through free vaccination for pertussis that is administered at 2, 4 and 6 months of age. The first dose can be provided as early as 6 weeks of age. There is also a booster dose at 3½ to 4 years. New parents and grandparents should also discuss the benefits of pertussis vaccination for themselves with their general practitioner. Gastroenteritis outbreaks in institutions NB: Data are current and accurate as at the preparation date. The number of cases reported is, however, subject to change, as cases may be entered at a later date or retracted upon further investigation. Data are reported by Local Health District of residence (geocoded to 2011 boundaries). Source: Notifiable Conditions Information Management System, NSW Ministry of Health.
